Infectious Disease

Pfizer, BioNTech, is officially asking the FDA to provide vaccines to the teenagers

April 09, 2021

1 min read

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

Pfizer and BioNTech announced on Friday that they have formally asked the FDA to make their COVID-19 vaccine available to adolescents ages 12-15 through emergency approval.

On Twitter, the companies were hoping that the vaccine for this age group would be available by the beginning of the next school year.

Source: Adobe Stock

Pfizer and BioNTech have asked the FDA to approve their COVID-19 vaccine for use in children ages 12-15.

“We plan to request similar decisions from other regulators around the world in the coming days,” the companies tweeted.

The request was anticipated. The companies announced last month that the vaccine would offer high levels of protection in children ages 12-15 who are in a Phase 3 study, and said they are applying for emergency approval in that age group would.

Experts, when expected, called the results “extremely exciting” and said emergency clearance could bring the country closer to full vaccination.

The vaccine is already approved in the US for emergencies for people aged 16 and over – the only COVID-19 vaccine so far available to children of all ages.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

COVID-19 Resource Center

COVID-19 Resource Center

Related Articles